Giotrif 40 mg

Giotrif 40 mg tablets contain afatinib dimaleate, a targeted therapy used in cancer treatment. This oral medication is designed to inhibit specific proteins involved in cancer cell growth.

Giotrif 40 mg tablets are primarily used in the treatment of certain types of cancer. Afatinib, the active ingredient, works by targeting and blocking specific proteins that help cancer cells grow and spread. This medication is often prescribed for non-small cell lung cancer and other conditions as determined by a healthcare provider. Patients may wonder, 'What is Giotrif used for?' and the answer lies in its ability to interfere with cancer cell proliferation.

Common effects of Giotrif 40 mg tablets may include skin reactions, diarrhea, and nausea. Some patients might experience appetite loss or fatigue. These effects can vary widely among individuals and are not exhaustive. Always consult a healthcare professional for personalized advice.

Giotrif 40 mg tablets should be handled with care. Store them at room temperature, away from moisture and heat. Keep the medication out of reach of children and pets. Follow the prescribed dosage and administration instructions provided by your healthcare provider.

Giotrif 40 mg tablets may interact with certain medications, including those that affect liver enzymes. Alcohol and other substances that impact liver function should be avoided. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.